You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

89Zr-TLX250

Showing 1 - 25 of 106
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clear Cell Renal Cell Carcinoma, Suspected Recurrent Renal Clear Cell Carcinoma, Recurrent Renal Cell Cancer Trial

Not yet recruiting
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • (no location specified)
May 14, 2023

Solid Tumor, Adult, Advanced Solid Tumor, Advanced Renal Cell Carcinoma Trial in Australia (89Zr-TLX250, 177Lu-TLX250 and

Recruiting
  • Solid Tumor, Adult
  • +2 more
  • 89Zr-TLX250
  • 177Lu-TLX250 and Peposertib
  • North Ryde, New South Wales, Australia
  • +4 more
May 22, 2023

Triple Negative Breast Cancer Trial in Saint-Herblain (89Zr-TLX250 PET/CT)

Recruiting
  • Triple Negative Breast Cancer
  • 89Zr-TLX250 PET/CT
  • Saint-Herblain, France
    ICO René Gauducheau
Oct 18, 2021

Carcinoma, Renal Cell, Clear Cell Renal Cell Carcinoma Trial in Yokohama City (89Zr-girentuximab)

Completed
  • Carcinoma, Renal Cell
  • Clear Cell Renal Cell Carcinoma
  • 89Zr-girentuximab
  • Yokohama City, Kanagawa, Japan
    Yokohama City University Hospital
Aug 18, 2021

Urothelial Carcinoma Trial in Murdoch (89Zr-Girentuximab)

Recruiting
  • Urothelial Carcinoma
  • Murdoch, Western Australia, Australia
    Fiona Stanley Hospital
Sep 8, 2021

Bladder Cancer Trial in Saint Herblain (89Zr-TLX250 PET/CT)

Recruiting
  • Bladder Cancer
  • 89Zr-TLX250 PET/CT
  • Saint Herblain, France
    Institut de cancerologie de l'Ouest
Nov 24, 2021

Clear Cell Renal Cell Carcinoma Trial in Worldwide (89Zr-girentuximab)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • 89Zr-girentuximab
  • Duarte, California
  • +29 more
Aug 4, 2021

Clear Cell Renal Cell Carcinoma Trial in Los Angeles (89Zr-DFO-girentuximab)

Available
  • Clear Cell Renal Cell Carcinoma
  • 89Zr-DFO-girentuximab
  • Los Angeles, California
    UCLA
Oct 12, 2023

Cervical Cancer, Colorectal Cancer, Esophageal Cancer Trial (89Zr-DFO-girentuximab)

Not yet recruiting
  • Cervical Cancer
  • +13 more
  • (no location specified)
Sep 28, 2022

Urothelial Carcinoma Trial in Murdoch (89Zr-Girentuximab)

Recruiting
  • Urothelial Carcinoma
  • Bladder Cancer
  • Murdoch, Western Australia, Australia
    Fiona Stanley Hospital
Aug 22, 2021

Multiple Myeloma, Plasma Cell Myeloma Trial in San Francisco (drug, procedure, other)

Not yet recruiting
  • Multiple Myeloma
  • Plasma Cell Myeloma
  • Zirconium Zr 89-DFO-YS5
  • +3 more
  • San Francisco, California
    University of California, San Francisco
May 26, 2023

Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Panitumumab
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Feb 16, 2023

Large B-cell Lymphoma, DLBCL Trial in New York (89Zr-DFO-REGN3767, PET/CT)

Recruiting
  • Large B-cell Lymphoma
  • DLBCL
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 3, 2022

Prostate Cancer Trial in New York (89Zr- DFO-MSTP2109A, 89Zr DFO-MSTP2109A)

Active, not recruiting
  • Prostate Cancer
  • 89Zr- DFO-MSTP2109A
  • 89Zr DFO-MSTP2109A
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 1, 2023

Multiple Myeloma Trial in Irvine (89Zr-daratumumab PET/CT)

Recruiting
  • Multiple Myeloma
  • 89Zr-daratumumab PET/CT
  • Irvine, California
    Hoag Memorial Hospital Presbyterian
Aug 1, 2022

Melanoma, Merkel Cell Carcinoma, Unspecified, Renal Cell Carcinoma Trial in Australia, Netherlands, United States

Recruiting
  • Melanoma
  • +3 more
  • 89Zr-Df-Crefmirlimab
  • Little Rock, Arkansas
  • +7 more
Jul 11, 2022

Angelman Syndrome Trial in Groningen (RO7248824)

Completed
  • Angelman Syndrome
  • Groningen, Netherlands
    Pra International Group B.V
Sep 7, 2022

Cancer Trial in Wuxi (89Zr-NY009)

Recruiting
  • Cancer
  • Wuxi, China
    Affiliated Hospital of Jiangnan University
Jan 19, 2023

Multiple Myeloma Trial in Wuxi (89Zr-NY008)

Recruiting
  • Multiple Myeloma
  • Wuxi, Jiangsu, China
    Affiliated Hospital of Jiangnan University
Dec 15, 2022

Advanced Solid Tumor, Metastatic Solid Tumor Trial (89Zr?DFO?REGN5054, cemiplimab)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
Aug 5, 2022

Breast Cancer Trial in Birmingham ([89Zr]-Df-Trastuzumab, PET/MRI Imaging)

Recruiting
  • Breast Cancer
  • Birmingham, Alabama
    The Kirklin Clinic
Feb 1, 2022

Advanced Solid Tumor Trial in Amsterdam, Groningen (89Zr-S095012 tracer and S095012 will be administered via an IV infusion)

Recruiting
  • Advanced Solid Tumor
  • 89Zr-S095012 tracer and S095012 will be administered via an IV infusion
  • Amsterdam, Netherlands
  • +1 more
Dec 9, 2022

Pancreatic Cancer Trial in Grand Rapids (NMK89)

Recruiting
  • Pancreatic Cancer
  • Grand Rapids, Michigan
    BAMF Health
Nov 8, 2023

Multiple Myeloma Trial (89Zr-DFO-daratumumab, PET/CT)

Withdrawn
  • Multiple Myeloma
  • (no location specified)
Jun 30, 2022

Pancreas Cancer Trial in Stanford (89Zr-panitumumab)

Suspended
  • Pancreas Cancer
  • Stanford, California
    Stanford University
Jun 15, 2022